- The key vendors in the Global Cervical Cancer Diagnostic Tests Market 2014-2018 are Abbott Laboratories Ltd., Becton, Dickinson and Co., F. Hoffmann-La Roche AG, Hologic Inc., Qiagen NV and Quest Diagnostics Inc.
London, 10 December 2014: TechNavio, an independent tech-focused global research firm, has announced the publication of its market research report on the Global Cervical Cancer Diagnostic Tests Market 2014-2018. The development of new diagnostic technologies is one key trend emerging in this market. Various organizations and companies are focusing on R&D to discover and identify new biomarkers to help in the accurate diagnosis of cervical cancer. The Global Cervical Cancer Diagnostic Tests market is expected to post a CAGR of 10.89 percent during the period 2013-2018.
“R&D for the development of new technologies to upgrade detection of cervical cancer and its precursors has increased owing to increased incidence of cervical cancer,” says Faisal Ghaus, Vice President of TechNavio Research.
“These new tests are designed to increase the early detection of significant and relevant Pap smear abnormalities, decrease the number of unsatisfactory smears, and yield lesser ambiguous results.”
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
